...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Vote - please
3
Oct 04, 2023 01:06PM
1
Oct 04, 2023 02:10PM
1
Oct 04, 2023 05:26PM

Toinv, I totalled the amount of "exempt distribution reportings" for the year.

 

Koo


Oct 04, 2023 09:04PM
1
Oct 05, 2023 07:14AM
Share
New Message
Please login to post a reply